Intest Res Search

CLOSE


Article category

  • HOME
  • ARTICLE CATEGORY
  • Article category
Infection
Whipple disease mimicking inflammatory bowel disease
Maiko Tatsuki, Takashi Ishige, Yoshiko Igarashi, Reiko Hatori, Akira Hokama, Junko Hirato, Aleixo Muise, Takumi Takizawa, Hirokazu Arakawa
Intest Res. 2021;19(1):119-125.   Published online July 3, 2020
Full text    PubReader    ePub    PDF    
Close layer
prev next
IBD
Rapid prediction of 1-year efficacy of tofacitinib for treating refractory ulcerative colitis
Hiromichi Shimizu, Toshimitsu Fujii, Shuji Hibiya, Maiko Motobayashi, Kohei Suzuki, Kento Takenaka, Eiko Saito, Masakazu Nagahori, Kazuo Ohtsuka, Mamoru Watanabe
Intest Res. 2021;19(1):115-118.   Published online June 11, 2020
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Miscellaneous
Patients with celiac disease are at high risk of developing metabolic syndrome and fatty liver
Ashish Agarwal, Alka Singh, Wajiha Mehtab, Vipin Gupta, Ashish Chauhan, Mahendra Singh Rajput, Namrata Singh, Vineet Ahuja, Govind K. Makharia
Intest Res. 2021;19(1):106-114.   Published online April 22, 2020
Full text    PubReader    ePub    PDF    
Close layer
prev next
Inflammatory Bowel Diseases
Population pharmacokinetics of vedolizumab in Asian and non-Asian patients with ulcerative colitis and Crohn’s disease
Hiroyuki Okamoto, Nathanael L. Dirks, Maria Rosario, Tetsuharu Hori, Toshifumi Hibi
Intest Res. 2021;19(1):95-105.   Published online July 10, 2020
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Efficacy and safety of vedolizumab in Crohn’s disease in patients from Asian countries in the GEMINI 2 study
Rupa Banerjee, Sai Wei Chuah, Ida Normiha Hilmi, Deng-Chyang Wu, Suk-Kyun Yang, Dirk Demuth, Dirk Lindner, Shashi Adsul
Intest Res. 2021;19(1):83-94.   Published online December 31, 2020
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Efficacy and safety of vedolizumab in ulcerative colitis in patients from Asian countries in the GEMINI 1 study
Choon Jin Ooi, Ida Normiha Hilmi, Hyo-Jong Kim, Umesh Jalihal, Deng-Chyang Wu, Dirk Demuth, Dirk Lindner, Shashi Adsul
Intest Res. 2021;19(1):71-82.   Published online September 4, 2020
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis
Yujin Jeong, Seong Ran Jeon, Hyun Gun Kim, Jung Rock Moon, Tae Hee Lee, Jae Young Jang, Jun-Hyung Cho, Jun Seok Park, Heesu Park, Ki-hun Lee, Jin-Oh Kim, Joon Seong Lee, Bong Min Ko, Suyeon Park
Intest Res. 2021;19(1):62-70.   Published online May 8, 2020
Full text    PubReader    ePub    PDF    
Close layer
prev next
Efficacy of biologic therapies for biologic-naïve Japanese patients with moderately to severely active ulcerative colitis: a network meta-analysis
Toshifumi Hibi, Isao Kamae, Philippe Pinton, Lyann Ursos, Ryuichi Iwakiri, Greg Hather, Haridarshan Patel
Intest Res. 2021;19(1):53-61.   Published online April 22, 2020
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
Quality of life in inflammatory bowel diseases: it is not all about the bowel
Ronald Keller, Nazar Mazurak, Laura Fantasia, Stefano Fusco, Nisar P Malek, Jan Wehkamp, Paul Enck, Thomas Klag
Intest Res. 2021;19(1):45-52.   Published online February 27, 2020
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
IBD
Endoscopic molecular imaging in inflammatory bowel disease
Nam Seok Ham, Seung-Jae Myung
Intest Res. 2021;19(1):33-44.   Published online April 20, 2020
Full text    PubReader    ePub    PDF    
Close layer
prev next
Close layer
prev next
Cancer
Two intertwined compartments coexisting in sporadic conventional colon adenomas
Carlos A. Rubio
Intest Res. 2021;19(1):12-20.   Published online February 24, 2020
Full text    PubReader    ePub    PDF    
Close layer
prev next
IBD
Pouchitis in inflammatory bowel disease: a review of diagnosis, prognosis, and treatment
Shintaro Akiyama, Victoria Rai, David T. Rubin
Intest Res. 2021;19(1):1-11.   Published online November 5, 2020
Full text    PubReader    ePub    PDF    
Close layer
prev next
Inflammatory bowel diseases
Long-term outcome after surgery in a patient with intestinal Behçet’s disease complicated by myelodysplastic syndrome and trisomy 8
Yuki Mori, Fumihiko Iwamoto, Yasuaki Ishida, Toru Kuno, Shoji Kobayashi, Takashi Yoshida, Tatsuya Yamaguchi, Tadashi Sato, Makoto Sudo, Daisuke Ichikawa, Nobuyuki Enomoto
Intest Res. 2020;18(4):469-475.   Published online May 12, 2020
Full text    PubReader    ePub    PDF    
Close layer
prev next
Functional bowel disorders
Psychological profiles of irritable bowel syndrome patients with different phenotypes
Michel Bouchoucha, Ghislain Devroede, Noëlle Girault-Lidvan, Maria Hejnar, Florence Mary, Robert Benamouzig
Intest Res. 2020;18(4):459-468.   Published online October 26, 2020
Full text    PubReader    ePub    PDF    Supplementary Material
Close layer
prev next
  • Journal Impact Factor 4.9
  • SCImago Journal & Country Rank
  • AOCC 2018
  • CSIBD
  • JSIBD
  • kasid
  • TSIBD
  • CCF
  • PubMed Central
  • PubMed
  • KoreaMed
  • KoMCI
  • Scopus
  • Directory of Open Access Journals (DOAJ)
  • GoogleScholar
  • EBSCO
  • Similarity Check
  • Crossref Cited-by Linking
  • CrossMark
  • Funder Registry
  • ORCID
  • COPE
  • KOFST
  • TrendMD

ABOUT
ARTICLE & TOPICS
Article Category

Browse all articles >

TOPICS

Browse all articles >

BROWSE ARTICLES
EDITORIAL POLICY
AUTHOR INFORMATION
Editorial Office
Room 310, Lotte Gold Rose II, 31 Seolleung-ro 86-gil, Gangnam-gu, Seoul 06193, Korea
Tel: +82-2-957-6145    Fax: +82-2-957-6146    E-mail: thekasid@irjournal.org                

Copyright © 2024 by Korean Association for the Study of Intestinal Diseases.

Developed in M2PI

Close layer
prev next